EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early Infection for Mass Production of Artificial Single-Stranded DNA with Escherichia coli

Nathalie Hafner, Nazanin Nematzadeh Somehsaraei, Maximilian N. Honemann, Hendrik Dietz, Dirk Weuster-Botz

Applied Sciences · 09.12.2024 · 14 (23) · 11459

DOI: 10.3390/app142311459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 09.12.2024. Verfasst von Nathalie Hafner und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Ministry of Education and Research (BMBF) and the Free State of Bavaria under the Excellence Strategy of the Federal Government and the Länder through….

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Large quantities of artificial single-stranded DNA (ssDNA) with user-defined sequences are increasingly required to exploit the potential of DNA nanotechnology. Cross-contamination-free ssDNA production can be achieved using Escherichia coli with an optimized helper plasmid in high-cell-density cultivation via the secretion of phagemid particles containing ssDNA with user-defined sequences. In our study, we aimed to reduce the number of phagemid particles for the initiation of ssDNA production. We tested different infection densities, ranging from a multiplicity of infection (MOI) of 10−6–10−2 tfu cfu−1 at the start of the initial batch phase in a 2.5 L stirred tank bioreactor. A MOI of 10−3 tfu cfu−1 was the best compromise between process time and ssDNA concentration. Early initiation of ssDNA production with low MOI reduced the number of phagemid particles by a factor of 250,000. The early infection strategy was successfully scaled up to the 25 L scale, resulting in ssDNA concentrations of >100 mg L−1 within a process time of one day. Transferring the infection strategy to a 1000 L scale gained 65 mg L−1 ssDNA because of incomplete initial infection. The versatility of the early infection strategy was further proven with a second prolonged, user-defined ssDNA sequence.

Förderung

  • Federal Ministry of Education and Research (BMBF) and the Free State of Bavaria under the Excellence Strategy of the Federal Government and the Länder through…

Zitieren

APA

Hafner, N., Somehsaraei, N. N., Honemann, M. N., Dietz, H., & Weuster-Botz, D. (2024). Early Infection for Mass Production of Artificial Single-Stranded DNA with Escherichia coli. Applied Sciences, 14(23), 11459. https://doi.org/10.3390/app142311459

Vancouver

Hafner N, Somehsaraei NN, Honemann MN, Dietz H, Weuster-Botz D. Early Infection for Mass Production of Artificial Single-Stranded DNA with Escherichia coli. Applied Sciences. 2024;14(23):11459. doi:10.3390/app142311459

BibTeX
@article{Hafner2024,
  author = {Hafner, Nathalie and Somehsaraei, Nazanin Nematzadeh and Honemann, Maximilian N. and Dietz, Hendrik and Weuster-Botz, Dirk},
  title = {Early Infection for Mass Production of Artificial Single-Stranded DNA with Escherichia coli},
  journal = {Applied Sciences},
  year = {2024},
  volume = {14},
  number = {23},
  pages = {11459},
  doi = {10.3390/app142311459}
}
Kostenlos starten →